Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples